Skip to content

mHealth Technology in People With Parkinson's Disease

Feasibility and Efficacy of a Home Exercise Program Using mHealth Technology in People With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05829915
Acronym
HomTrainPark
Enrollment
114
Registered
2023-04-26
Start date
2023-03-30
Completion date
2025-04-30
Last updated
2025-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

The main objective of the study is to explore the feasibility and effectiveness of this type of mHalth technology in the treatment of motor symptoms in people with Parkinson's disease.

Detailed description

Parkinson's disease (PD) is a neurological disease whose motor symptoms drastically affect the quality of life of those who suffer from it. There is currently high scientific evidence of the positive effect of physical exercise on the motor function of people with PD. This effect seems to be more relevant when this physical exercise is implemented with external sensory signals (eg visual, auditory). However, the health and socioeconomic context of the patient conditions their access to treatments and physical exercise programs, associationism being common as a low-cost strategy to cover the different therapies. The development of telemedicine, electronic devices and mobile health applications could be an interesting option for those patients who find themselves in the situations mentioned above. However, there are several limitations regarding the use of mobile health apps, such as that less than 1% of them are grounded in research evidence and the digital barrier. Therefore, the main objective of the study is to explore the feasibility and effectiveness of this type of mHalth technology in the treatment of motor symptoms in people with Parkinson's disease.

Interventions

DEVICEROXPro© system (A-Champs)

The intervention consisted in 24 sessions (3/week) of a cognitive-multisensory-physical exercise program carried out in the patient's own home. The exercise program was designed by qualified personal trainers and psychologists, and implemented with the ROXPro© system (A-Champs) (https://a-champs.com; accessed on 8 January 2022). This system consists of small devices that provide visual, auditory and vibration stimuli with which the patient interacts. Through its mobile application, it allows the development of numerous sensory-cognitive-motor exercises adapted to the characteristics of the patients.

OTHERNo exercise program

The control group did not received the physical exercise program

Sponsors

Universidad Rey Juan Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Absence of treatment with psychotropic drugs or stable dose of the same (without drug or dose modifications in the last four weeks). In the case of subjects who are part of the intervention group, the following will also be inclusion criteria: * Caregiver or family member who presents the appropriate skills for collaboration in the implementation of the exercises and in the management of the mobile application. * Availability of the necessary time for the initial training in the handling of the devices, the development of the sessions and the communication with the researchers.

Exclusion criteria

* Insufficient physical condition for participation. * Sensory deficits that make participation difficult. * Unstable clinical situation. * Unstable mental disorder or not adequately controlled with medication (depression, agitation, etc.). * Presence of associated pathology that involves treatment with drugs that alter cognitive abilities or interfere with the user's participation

Design outcomes

Primary

MeasureTime frameDescription
Speed of gait at preferred pacebaselineSpeed (m/s)
Cadence of gait at preferred paceBaselinecadence (steps/min)
Step Length of gait at preferred paceBaselineStep Length (m)

Secondary

MeasureTime frameDescription
Time up & go testBaselineTime (seconds)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026